Higher uptake was evident in AD and minimal in MAPT mutation carriers with a mutation on exon 10, while higher uptake, similar to the AD pattern, was observed in patients with MAPT mutations outside exon 10. The gene discussed is MAPT; the disease is Alzheimer disease.